AKUMSAkums Drugs and Pharmaceuticals Limited
Pharma · Drug Manufacturers - Specialty & Generic · NSE · as of 2026-07-20 (delayed ~30 min in market hours)
₹677.00
▲ 1.81%Decent
Price & Volume
Loading chart…
Key Ratios
Market Cap (₹ cr)10,596.20
P/E41.29
P/B3.20
PEG—
ROE %8.02
ROCE %10.70
Debt / Equity0.06
EPS16.76
Revenue Growth %9.60
Profit Growth %-42.60
Dividend Yield %0.43
Promoter Holding %80.17
FII Holding %13.24
DII Holding %—
Beta1.07
“—” means the figure isn't meaningful or isn't published for this company: ROE and Debt/Equity are undefined when shareholder equity is negative (check P/B — negative means negative equity), and DII/MF holding splits aren't provided by our current data source.
Active Pattern Signals
| Pullback to 21-EMA | LONG | 80% | ₹677.00 | ₹650.25 | ₹741.45 | 2.41 |
HOLDConviction 69%
The picture
- • Debt/Equity: 0.06
- • Promoter holding: 80.2%
- • Valuation vs sector: P/E 41.3 vs sector 37.1
- • RSI: 64
- • Price vs EMA21: above
- • Price vs SMA50: above
- • Pullback to 21-EMA signal (setup quality 80%)
Bull case
- • Debt/Equity: 0.06
- • Promoter holding: 80.2%
- • Valuation vs sector: P/E 41.3 vs sector 37.1
- • RSI: 64
Bear case
- • Profit growth: -42.6% YoY
- • ROE: 8.0%
- • MACD: bearish
- • Volume: 0.5x 20-day average
Key risks
- • Profit growth: -42.6% YoY
- • ROE: 8.0%
Algorithmic analysis for research only — not SEBI-registered investment advice.
Trade Plan
Entry (CMP)
₹677.00
Stop Loss
₹618.19
risk 8.7%
Target 1 (1.5R)
₹765.22
+13.0%
Target 2 (3R)
₹853.44
+26.1%
Support (20d)
₹604.74
Resistance (52w)
₹714.70
Risk : Reward
1 : 1.5 → 1 : 3
risking ₹58.81/share
ATR (volatility)
₹23.53
avg daily range
Stop = 20-day support with a 2.5×ATR risk cap (ATR ₹23.53). Levels recompute on every data refresh. Position sizing and execution are yours — this is analysis, not advice.
Score Breakdown
Fundamental
45
Technical
71
Momentum
93
Risk (safety)
76